NCT03385720 Submandibular Gland Preservation in Neck Dissection
| NCT ID | NCT03385720 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Guang-Yan Yu |
| Condition | Neck Dislocation |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2017-12-05 |
| Primary Completion | 2023-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2017-12-05 with a primary completion date of 2023-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Trial design: a randomized controlled trial. Eligibility criteria for participants: patients with primary early stage oral squamous cell carcinoma. Exclusion criteria: cancer of the floor of the mouth. Interventions: submandibular gland is preserved during neck dissection for patients of the experimental group; submandibular gland is removed during neck dissection for patients of the control group. Primary Parameters: survival rate, mortality rate
Eligibility Criteria
Inclusion Criteria: Primary oral squamous cell carcinoma of early stage (T1N0 and T2N0). Exclusion Criteria: Cancer of the floor of the mouth.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT03385720 clinical trial?
This trial is open to participants of all sexes, up to 90 Years, studying Neck Dislocation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03385720 currently recruiting?
Yes, NCT03385720 is actively recruiting participants. Contact the research team at sujiazeng@163.com for enrollment information.
Where is the NCT03385720 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT03385720 clinical trial?
NCT03385720 is sponsored by Guang-Yan Yu. The trial plans to enroll 200 participants.